Cintas (CTAS)
NASDAQIndustrialsSpecialty Business ServicesSnapshot 2026-07-07
$181.83+2.01%
Close 2026-07-07 · 1-day change
Reading CTAS? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track CTAS free→NASDAQIndustrialsSpecialty Business ServicesSnapshot 2026-07-07
Reading CTAS? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track CTAS free→QuarterlyIQ Insights · CTAS
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 13 valuation methods, at three horizons. Current price $181.83. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 25% on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $182 the market pays 38× p/e — above the 29× p/e peer median but in line with its own 37× history. That premium reflects a durable franchise our peer-anchored $119 fair value understates; treat the 'expensive vs peers' read with medium confidence. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Flags: expensive valuation, weak execution quality. Capped at elevated by the Mania regime.
For similar setups historically (n=2,301): about 43% saw a 20%+ drawdown, and roughly 77% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
At today's price you pay about 63% over what the business is worth with no growth; closing that gap needs roughly 7.6 years of the forecast growth to come through. These describe the expectations embedded in the price, not a forecast of the move. Reverse-DCF base: $4.73/sh owner earnings.
Looks more expensive than peers.
Around its own typical valuation.
Trailing four: 2025-Q3, 2026-Q1, 2026-Q2, 2026-Q3
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| dcf fcfe | 12M | $150.56 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $147.10 | — | — | Hist. CAGR | high |
| ddm gordon | 12M | $40.33 | — | — | TTM | high |
| graham number | 12M | $35.52 | — | — | TTM | high |
| Mgmt guidance | 12M | $142.80 | 29.3 | 4.88 | Mgmt | high |
| Peer EV/EBITDA | 12M | $107.09 | 15.0 | 7.54 | TTM | high |
| Peer P/FCF | 12M | $86.15 | 19.5 | 4.42 | TTM | high |
| Peer P/E | 12M | $139.28 | 29.3 | 4.76 | TTM | high |
| Peer P/S | 12M | $43.42 | 1.6 | 27.25 | TTM | high |
| PEG | 12M | $187.47 | 39.4 | 4.76 | TTM | high |
| residual income | 12M | $27.91 | — | — | TTM | high |
| Own P/E history | 12M | $177.01 | 37.2 | 4.76 | TTM | high |
| triangulated | 12M | $144.53 | 29.3 | 4.94 | Triangulated | high |
| Mgmt guidance | 3Y | $224.52 | 29.3 | 7.67 | Mgmt(prov.) | medium |
| Peer P/FCF | 3Y | $118.95 | 19.5 | 6.10 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $161.51 | 29.3 | 5.52 | Analyst | medium |
| Peer P/S | 3Y | $48.29 | 1.6 | 30.31 | guidance | medium |
| PEG | 3Y | $217.40 | 39.4 | 5.52 | Analyst | medium |
| Own P/E history | 3Y | $205.27 | 37.2 | 5.52 | Analyst | medium |
| Mgmt guidance | 5Y | $303.57 | 29.3 | 10.37 | Mgmt(prov.) | high |
| Peer P/FCF | 5Y | $147.50 | 19.5 | 7.57 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $167.14 | 29.3 | 5.71 | Analyst | high |
| Peer P/S | 5Y | $49.97 | 1.6 | 31.36 | guidance | high |
| PEG | 5Y | $224.97 | 39.4 | 5.71 | Analyst | high |
| Own P/E history | 5Y | $212.41 | 37.2 | 5.71 | Analyst | high |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.